141 related articles for article (PubMed ID: 9423794)
1. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.
Karpman D; Lethagen S; Kristoffersson A; Isaksson C; Holmberg L
Thromb Haemost; 1997 Dec; 78(6):1456-62. PubMed ID: 9423794
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura.
Karpman D; Holmberg L; Jirgård L; Lethagen S
Kidney Int; 1996 Jan; 49(1):190-9. PubMed ID: 8770967
[TBL] [Abstract][Full Text] [Related]
3. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P
Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
5. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow.
Galbusera M; Remuzzi A; Benigni A; Rossi C; Remuzzi G
Am J Kidney Dis; 2000 Oct; 36(4):695-702. PubMed ID: 11007670
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura.
Moake JL
Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504
[TBL] [Abstract][Full Text] [Related]
7. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
Tatewaki W
Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
[TBL] [Abstract][Full Text] [Related]
8. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
9. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
Kumar RA; Moake JL; Nolasco L; Bergeron AL; Sun C; Dong JF; McIntire LV
Biorheology; 2006; 43(5):681-91. PubMed ID: 17047284
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
11. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura.
Moake JL
Thromb Haemost; 1995 Jul; 74(1):240-5. PubMed ID: 8578465
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura.
Jilma-Stohlawetz P; Gorczyca ME; Jilma B; Siller-Matula J; Gilbert JC; Knöbl P
Thromb Haemost; 2011 Mar; 105(3):545-52. PubMed ID: 21174003
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.
Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A
Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682
[TBL] [Abstract][Full Text] [Related]
15. Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.
Du VX; van Os G; Kremer Hovinga JA; Dienava-Verdoold I; Wollersheim J; Ruggeri ZM; Fijnheer R; de Groot PG; de Laat B
Br J Haematol; 2012 Oct; 159(1):94-103. PubMed ID: 22881339
[TBL] [Abstract][Full Text] [Related]
16. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
Moake JL
Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
[No Abstract] [Full Text] [Related]
17. Binding of platelet agglutinating protein p37 from the plasma of a patient with thrombotic thrombocytopenic purpura to human platelets.
Lian EC; Siddiqui FA
Thromb Haemost; 1991 Jan; 65(1):96-101. PubMed ID: 2024244
[TBL] [Abstract][Full Text] [Related]
18. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
[TBL] [Abstract][Full Text] [Related]
19. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.
Chow TW; Turner NA; Chintagumpala M; McPherson PD; Nolasco LH; Rice L; Hellums JD; Moake JL
Am J Hematol; 1998 Apr; 57(4):293-302. PubMed ID: 9544973
[TBL] [Abstract][Full Text] [Related]
20. [The changes in von Willebrand factor multimer in a course of thrombotic thrombocytopenic purpura].
Saitoh M; Wada H; Tanigawa M; Tamaki S; Masuya M; Minami N; Deguchi K; Shirakawa S; Tatewaki W; Takahashi H
Rinsho Ketsueki; 1991 Sep; 32(9):1006-8. PubMed ID: 1942536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
